The FormuTech Summit returns in 2026 with an expanded vision, uniting a global community of innovators shaping the future of RNA-based therapeutics. As mRNA and LNP technologies rapidly evolve toward more sophisticated, scalable, and globally accessible applications, the summit serves as a key meeting point for industry leaders, scientists, engineers, and regulators to exchange insights and accelerate progress. Hosted in Lisbon, one of Europe’s most dynamic and fast-growing biotech hubs, FormuTech 2026 provides an exceptional environment for strategic collaboration, scientific dialogue, and high-value networking.
This year’s edition will spotlight the most pressing and high-interest themes identified by the community — including emerging technologies and process automation, regulatory and compliance expectations, data integrity and governance, and the growing need for analytical harmonization across RNA and LNP platforms. Attendees will explore advancements in digital and AI-enabled development, next-generation characterization tools, improved approaches for reliability and reproducibility, and innovative strategies to elevate product quality, safety, and manufacturability. The summit will also highlight collaborative models, cross-functional workflows, and the role of global governance in supporting the maturation of RNA technologies from exploratory R&D to large-scale deployment.
Across two days, FormuTech Summit 2026 will deliver a curated scientific agenda featuring expert presentations, panel discussions, case studies, and interactive sessions addressing the most urgent challenges and opportunities in mRNA and LNP development. Participants will gain practical, actionable insights to accelerate development timelines, strengthen analytical readiness, improve regulatory alignment, and adopt transformative technologies that are reshaping the future of RNA therapeutics.
FormuTech Summit 2026 continues its mission to bring together the leading minds of the RNA ecosystem. Join us in Lisbon to connect with global experts, discover breakthrough innovations, and contribute to shaping the next era of mRNA and LNP science.
1. Synthetic Biology for RNA-Compatible Therapeutics
Discover how RNA-adapted synthetic biology is enabling programmable gene expression, engineered immune responses, and new therapeutic architectures for human health.
2. Next-Generation mRNA–LNP Platforms for Vaccines & Therapeutics
Explore advanced LNP architectures, targeting strategies, and formulation approaches driving the next wave of vaccine and therapeutic development.
3. Scalable, Modular & Automated Manufacturing Systems
Learn how integrated, automated, and continuous RNA manufacturing platforms accelerate development, reduce cost, and support global GMP readiness.
4. Analytical Harmonization & Quality Standards for RNA/LNP Products
Examine harmonized analytical methods, orthogonal assays, and QC strategies needed to ensure consistent, comparable, and regulatory-accepted RNA products.
5. Digitalization, AI & Data Governance in RNA Development
Understand how AI-driven design, digital process control, and strong data-integrity frameworks are transforming R&D, scale-up, and GMP operations.
6. Improving LNP Potency, Targeting & Payload Diversity
Review emerging lipid chemistries, multifunctional LNP systems, and precision-targeting methods enhancing potency and supporting new RNA modalities.
7. Thermostability & Global Distribution Solutions for RNA Products
Learn about stabilizing technologies and formulation strategies enabling RNA medicines to withstand broader temperature ranges and expand global access.
8. Safety & Immunogenicity in Repeated RNA/LNP Dosing
Address top industry concerns around inflammatory responses, biodistribution, and reducing toxicity for chronic or repeated therapeutic use.
9. Innovations in IVT & Template Engineering
Discover advances in synthetic DNA templates, dsRNA minimization, enzymatic optimization, and new IVT technologies improving yield and purity.
10. Regulatory & CMC Readiness for Emerging RNA Modalities
Gain clarity on evolving global expectations for CMC integration, quality-by-design frameworks, and regulatory pathways for next-generation RNA products.
11. End-to-End GMP Manufacturing from pDNA to LNP
Evaluate integrated production workflows spanning plasmid DNA, high-yield IVT, purification, and LNP assembly under unified GMP and compliance frameworks.
12. Future Horizons in RNA Delivery & Therapeutic Technology
Preview disruptive innovations — such as programmable RNA circuits, synthetic-biology-powered drug responses, EV-based RNA delivery, and adaptive LNP systems.
Over 20+ Sessions , several networking opportunities in a special venue chosen by our team makes this event unique and unforgettable
Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors and Heads of departments of:
14 – 15 October, 2026 | Lisbon, Portugal
© 2017 Copyright All Rights Reserved | Powered by EPM Group